Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -.--% | -.--% |
07:43am | Roche Secures CE Mark for AI-powered Continuous Glucose Monitoring Device | MT |
05:36am | Roche Secures FDA Nod to Relaunch Susvimo in US After Recall | MT |
Business Summary
Sales per Business
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals
76.6
%
| 48,628 | 73.2 % | 46,279 | 76.6 % | -4.83% |
Diagnostics
23.4
%
| 17,798 | 26.8 % | 14,162 | 23.4 % | -20.43% |
Sales per region
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
46.9
%
| 29,313 | 44.1 % | 28,352 | 46.9 % | -3.28% |
Rest of Europe
16.1
%
| 10,328 | 15.5 % | 9,703 | 16.1 % | -6.05% |
Rest of Asia
14.7
%
| 9,852 | 14.8 % | 8,890 | 14.7 % | -9.76% |
Japan
7.4
%
| 6,452 | 9.7 % | 4,464 | 7.4 % | -30.81% |
Latin America
4.9
%
| 2,870 | 4.3 % | 2,971 | 4.9 % | +3.52% |
Germany
4.8
%
| 3,318 | 5.0 % | 2,893 | 4.8 % | -12.81% |
Africa, Australia and Oceania
2.0
%
| 1,520 | 2.3 % | 1,212 | 2.0 % | -20.26% |
Switzerland
1.8
%
| 1,671 | 2.5 % | 1,118 | 1.8 % | -33.09% |
Rest of North America
1.4
%
| 1,102 | 1.7 % | 838 | 1.4 % | -23.96% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 02-12-31 | |
Severin Schwan
CHM | Chairman | 57 | 07-12-31 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 11-03-31 |
Pascale Schmidt
CMP | Compliance Officer | 51 | 19-12-31 |
Levi Garraway
CTO | Chief Tech/Sci/R&D Officer | - | - |
Bruno Eschli
IRC | Investor Relations Contact | - | - |
Silke Hörnstein
PRN | Corporate Officer/Principal | 49 | 14-12-31 |
Annette Luther
SEC | Corporate Secretary | 54 | 20-03-31 |
General Counsel | 60 | 20-03-31 | |
Human Resources Officer | 57 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 15-03-02 |
Director/Board Member | 59 | - | |
Director/Board Member | 66 | 95-12-31 | |
Patrick Frost
BRD | Director/Board Member | 56 | 20-03-16 |
Hans Clevers
PRN | Corporate Officer/Principal | 67 | 19-03-04 |
Severin Schwan
CHM | Chairman | 57 | 07-12-31 |
Anita Hauser
BRD | Director/Board Member | 55 | 17-03-13 |
Director/Board Member | 71 | 15-03-02 | |
Director/Board Member | 58 | 16-02-29 | |
Joerg Duschmale
BRD | Director/Board Member | 40 | 20-03-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 106,691,000 | 28,989,189 ( 27.17 %) | 0 | 88.91 % |
Stock B | 1 | 702,562,700 | 690,549,674 ( 98.29 %) | 12,011,755 ( 1.710 %) |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
1,005,670,000 | 59.89% | 35,735,477,780 $ | |
ROCHE HOLDING AG 1.43% | 10,073,029 | 1.43% | 2,796,818,103 $ |
2,744,120 | 7.39% | 39,103,710 $ | |
454,961 | 3.02% | 10,327,615 $ | |
ALIGOS THERAPEUTICS, INC. 14.70% | 11,025,941 | 14.70% | 3,859,079 $ |
1,893 | 0.06% | 1,306 $ |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Viewics India Pvt Ltd.
| |
Roche Financial Investments Ltd.
| |
Roche Diagnostics Belgium NV
Roche Diagnostics Belgium NV BiotechnologyHealth Technology Part of Roche Holding AG, Roche Diagnostics Belgium NV is a Belgian company that develops innovative products and services for the prevention, diagnosis, monitoring, screening, and treatment of diseases. Roche Diagnostics Belgium is based in Diegem, Belgium, and was founded in 1958. The company offers next-generation sequencing products and in vitro diagnostics that are an integral part of decision-making along the entire continuum of a patient's health or disease. The CEO is Thomas Schinecker. |
Biotechnology
|
Roche Finance Europe BV
|
Finance/Rental/Leasing
|
Roche Financial Management Ltd.
| |
Roche Catalyst Investments Ltd.
| |
Roche Intertrade Ltd.
| |
Roche Pharmholding BV
Roche Pharmholding BV Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharmholding BV is a Dutch company that manufactures and distributes pharmaceutical and vitamin products. The company is based in Woerden, Netherlands. |
Medical Distributors
|
Sapac Corp. Ltd.
|
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.48% | 827B | |
-7.18% | 350B | |
+15.37% | 319B | |
+7.45% | 294B | |
+13.62% | 240B | |
+14.55% | 221B | |
+8.14% | 167B | |
-2.99% | 158B | |
+2.61% | 125B |
- Stock Market
- Equities
- ROG Stock
- RHO Stock
- Company Roche Holding AG